Jack Henkin

6.1k total citations
111 papers, 4.8k citations indexed

About

Jack Henkin is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Jack Henkin has authored 111 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cancer Research, 52 papers in Molecular Biology and 30 papers in Oncology. Recurrent topics in Jack Henkin's work include Protease and Inhibitor Mechanisms (49 papers), Blood Coagulation and Thrombosis Mechanisms (24 papers) and Peptidase Inhibition and Analysis (24 papers). Jack Henkin is often cited by papers focused on Protease and Inhibitor Mechanisms (49 papers), Blood Coagulation and Thrombosis Mechanisms (24 papers) and Peptidase Inhibition and Analysis (24 papers). Jack Henkin collaborates with scholars based in United States, United Kingdom and Canada. Jack Henkin's co-authors include Andrew P. Mazar, Shafaat A. Rabbani, Jieyi Wang, Olga V. Volpert, Pingping Lou, Rick Lesniewski, David Goltzman, Donald J. Davidson, Andrew J. Schneider and Dudley K. Strickland and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Jack Henkin

111 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jack Henkin United States	42	2.5k	2.1k	1.3k	881	532	111	4.8k
Catherine Butterfield United States	22	3.8k 1.5×	1.8k 0.9×	1.4k 1.1×	521 0.6×	731 1.4×	33	6.5k
George P. Tuszynski United States	44	3.1k 1.2×	1.4k 0.7×	804 0.6×	801 0.9×	424 0.8×	104	4.9k
Brunhilde Felding‐Habermann United States	28	2.4k 0.9×	1.1k 0.5×	2.0k 1.5×	787 0.9×	821 1.5×	43	5.4k
Mario Del Rosso Italy	40	2.2k 0.9×	1.3k 0.6×	816 0.6×	509 0.6×	247 0.5×	145	4.1k
Shafaat A. Rabbani Canada	50	3.9k 1.6×	2.2k 1.0×	2.5k 2.0×	684 0.8×	1.1k 2.1×	136	6.7k
Bruce A. Keyt United States	31	5.1k 2.0×	1.6k 0.8×	950 0.8×	1.7k 1.9×	727 1.4×	79	9.9k
Walter E. Laug United States	33	1.6k 0.6×	1.3k 0.6×	747 0.6×	511 0.6×	290 0.5×	73	3.6k
John D. Hooper Australia	35	1.9k 0.8×	1.1k 0.5×	1.1k 0.8×	820 0.9×	468 0.9×	120	4.1k
L. A. Liotta United States	21	3.0k 1.2×	1.8k 0.9×	1.7k 1.3×	266 0.3×	483 0.9×	39	4.9k
Giulia Taraboletti Italy	47	4.0k 1.6×	2.2k 1.0×	2.1k 1.7×	514 0.6×	506 1.0×	112	7.1k

Countries citing papers authored by Jack Henkin

Since Specialization

Citations

This map shows the geographic impact of Jack Henkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Henkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Henkin more than expected).

Fields of papers citing papers by Jack Henkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Henkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Henkin. The network helps show where Jack Henkin may publish in the future.

Co-authorship network of co-authors of Jack Henkin

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Henkin. A scholar is included among the top collaborators of Jack Henkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Henkin. Jack Henkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wysocki, Jan, Vlad Nicolaescu, Derek Elli, et al.. (2024). Soluble Angiotensin-Converting Enzyme 2 Protein Improves Survival and Lowers Viral Titers in Lethal Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection with the Delta Variant. Cells. 13(3). 203–203. 3 indexed citations

Harel, Michal, et al.. (2024). PEDF-derived peptide protects against Amyloid-β toxicity in vitro and prevents retinal dysfunction in rats. Experimental Eye Research. 242. 109861–109861. 1 indexed citations

Wysocki, Jan, Jared T. Ahrendsen, Minghao Ye, et al.. (2023). Intranasal soluble ACE2 improves survival and prevents brain SARS-CoV-2 infection. Life Science Alliance. 6(7). e202301969–e202301969. 6 indexed citations

Chan, Tiffany Sin Yu, Daniel Picard, Cynthia Hawkins, et al.. (2021). Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma. Neuro-Oncology Advances. 3(1). vdab002–vdab002. 4 indexed citations

Ferber, Shiran, Galia Tiram, Ana Sousa‐Herves, et al.. (2017). Co-targeting the tumor endothelium and P-selectin-expressing glioblastoma cells leads to a remarkable therapeutic outcome. eLife. 6. 79 indexed citations

Greenaway, James, et al.. (2011). ABT-898 Induces Tumor Regression and Prolongs Survival in a Mouse Model of Epithelial Ovarian Cancer. Molecular Cancer Therapeutics. 10(10). 1876–1885. 32 indexed citations

McFarland, Braden C., Amal H. Hamza, Robert Nordal, et al.. (2009). Plasminogen Kringle 5 Induces Apoptosis of Brain Microvessel Endothelial Cells: Sensitization by Radiation and Requirement for GRP78 and LRP1. Cancer Research. 69(13). 5537–5545. 40 indexed citations

Yang, Qiwei, Yufeng Tian, Shuqing Liu, et al.. (2007). Thrombospondin-1 Peptide ABT-510 Combined with Valproic Acid Is an Effective Antiangiogenesis Strategy in Neuroblastoma. Cancer Research. 67(4). 1716–1724. 70 indexed citations

Rusk, Anthony, David M. Vail, Joanne C. Graham, et al.. (2006). Cooperative Activity of Cytotoxic Chemotherapy with Antiangiogenic Thrombospondin-I Peptides, ABT-526 in Pet Dogs with Relapsed Lymphoma. Clinical Cancer Research. 12(24). 7456–7464. 20 indexed citations

10.

Kawai, Megumi, Nwe Y. BaMaung, Steve Fidanze, et al.. (2006). Development of sulfonamide compounds as potent methionine aminopeptidase type II inhibitors with antiproliferative properties. Bioorganic & Medicinal Chemistry Letters. 16(13). 3574–3577. 41 indexed citations

11.

Davidson, Donald J., Catherine J. Haskell, David A. Egan, et al.. (2005). Kringle 5 of Human Plasminogen Induces Apoptosis of Endothelial and Tumor Cells through Surface-Expressed Glucose-Regulated Protein 78. Cancer Research. 65(11). 4663–4672. 194 indexed citations

12.

Yap, Ronald L., Dorina Veliceasa, Urban Emmenegger, et al.. (2005). Metronomic Low-Dose Chemotherapy Boosts CD95-Dependent Antiangiogenic Effect of the Thrombospondin Peptide ABT-510: A Complementation Antiangiogenic Strategy. Clinical Cancer Research. 11(18). 6678–6685. 74 indexed citations

13.

Wang, Jieyi, Pingping Lou, Rick Lesniewski, & Jack Henkin. (2003). Paclitaxel at ultra low concentrations inhibits angiogenesis without affecting cellular microtubule assembly. Anti-Cancer Drugs. 14(1). 13–19. 170 indexed citations

14.

Reiher, Frank, Olga V. Volpert, Benilde Jiménez, et al.. (2002). Inhibition of tumor growth by systemic treatment with thrombospondin‐1 peptide mimetics. International Journal of Cancer. 98(5). 682–689. 106 indexed citations

15.

Weaver, Alissa M., Isa M. Hussaini, Andrew P. Mazar, Jack Henkin, & Steven L. Gonias. (1997). Embryonic Fibroblasts That Are Genetically Deficient in Low Density Lipoprotein Receptor-related Protein Demonstrate Increased Activity of the Urokinase Receptor System and Accelerated Migration on Vitronectin. Journal of Biological Chemistry. 272(22). 14372–14379. 86 indexed citations

16.

Bognacki, John, et al.. (1996). Interaction of single-chain urokinase with its receptor induces the appearance and disappearance of binding epitopes within the resultant complex for other cell surface proteins. Blood. 88(2). 542–551. 48 indexed citations

17.

Burke, Sandra E., et al.. (1996). DIFFERENTIAL EFFECTS OF LYS- AND MINI-PLASMINOGEN ON CLOT LYSIS INDUCED BY RECOMBINANT UROKINASE AND RECOMBINANT PRO-UROKINASE IN A CANINE THROMBOSIS MODEL. Thrombosis Research. 83(6). 421–431. 5 indexed citations

18.

Henkin, Jack, et al.. (1991). High sialic acid content slows prourokinase turnover in rabbits. Thrombosis Research. 63(2). 215–225. 8 indexed citations

19.

Badylak, Stephen F., Sherry L. Voytik, Richard E. Klabunde, Jack Henkin, & Michael L. Leski. (1988). Bolus dose response characteristics of single chain urokinase plasminogen activator and tissue plasminogen activator in a dog model of arterial thrombosis. Thrombosis Research. 52(4). 295–312. 26 indexed citations

20.

Liehr, Joachim G., Beverly B. DaGue, Annie M. Ballatore, & Jack Henkin. (1983). Diethylstilbestrol (DES) quinone: A reactive intermediate in DES metabolism. Biochemical Pharmacology. 32(24). 3711–3718. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact